Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Improve glycemic control with type 2 diabetes mellitus Condition: Initial |
Dose: Oral – 5 mg Frequency: once daily in morning Note: Indicated as an adjunct to diet and exercise to improve glycemic control with type 2 diabetes mellitus |
|
Indication: Improve glycemic control with type 2 diabetes mellitus Condition: Additional glycemic control required |
Dose: Oral – 10 mg Frequency: once daily Note: May increase to 10 mg once daily in patients tolerating 5 mg/day who require additional glycemic control |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: Dose: Note: Safety and efficacy not established |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment eGFR greater than 45 mL/min/1.73 m2 |
Dose: Not specified Note: No dosage adjustment required |
|
Indication: Type 2 Diabetes Mellitus Condition: Renal impairment eGFR 25 to less than 45 mL/min/1.73 m2 |
Dose: Not specified Note: Not recommended |
Administration
- Take in morning
- Can take with or without food
Side Effect
- Renal impairment
- Female genital mycotic infections (6.9-8.4%)
- Urinary Tract Infection (UTI) (4.3-5.7%)
- Increased urination (2.9-3.8%)
- Male genital mycotic infections (2.7-2.8%)
- Dyslipidemia (2.1-2.5%)
- Constipation (1.9-2.2%)
- Discomfort with urination (2.6-2.1%)
- Extremity pain (1.7-2%)
- Volume depletion
- Hypersensitivity (0.3%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Insulin, insulin secretagogues (e.g. sulfonylureas)
|
Hypoglycemia may occur with concomitant use
|
|
Rifampin
|
Decrease in Cmax & AUC
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Drug Hypersensitivity
|
Risk of allergic reaction
|
|
Moderate to Severe Renal Impairment
|
Risk of kidney complications
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.